VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Greg22 who wrote (18096)	1/24/1999 6:51:00 PM
From: DaiS	Read Replies (1) of 23519

Gr&St, I agree. All these crap companies with no product nor profits and massive share price do so on the basis of a dream and a wish. When they actually have a crap product to sell they will fall from the stars. If vivus only had muse now I would not be prepared to pay more than say ten years 1999 prospective earnings per share. On this basis $10 might be a fair price. Take away muse, alibra from Vivus, leave the gene therapy, change the name to GEN-ED, new management. ((Maybe we could add in possibility that the therapy might also be applied to other conditions where additional K-channels beneficial.)) Have a bit of a media splash when company launched and phase I trials.....gene therapy for ED to replace viagra, pills...blah, blah. I bet each of 30M shares would be worth more than $3. And again it would be on a dream and a prayer for we do not yet have this gene therapy for ED. I assume that at the cc we will hear something about the diabetic rats. But I am more interested in the progress of the work on assuring even distribution of the injected DNA construct. With a bit more advance in this area I think there will be the phase I trials. DaiS

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next